Ergoteles’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-35,922	Closed	-$649K	–	331
2023 Q2	$649K	Buy	+35,922	New	+$649K	0.03%	584
2022 Q3	–	Sell	-20,600	Closed	-$144K	–	1676
2022 Q2	$144K	Buy	+20,600	New	+$144K	﹤0.01%	1429